Mission Statement:

Boulder BioScience’s mission is to develop new therapeutic interventions for infectious and thrombotic disease. Our immediate goal is to leverage scientific discoveries and new formulation technology into the rapid clinical development of a first-in-class API for Covid 19. Our lead drug candidate delivers a small molecule immune modulator already supported by pre-clinical safety data and early clinical trial development. The drug candidate has a unique mechanism of action to modulate overactive innate immunity, reducing unwanted immune cell damage to the patient.

About Boulder BioScience